We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
KRMD

Price
3.38
Stock movement down
-0.04 (-0.96%)
Company name
Repro Med Systems Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Medical Instruments & Supplies
Market cap
190.03M
Ent value
190.88M
Price/Sales
5.94
Price/Book
10.72
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
82.67%
3 year return
17.71%
5 year return
-16.27%
10 year return
25.62%
Last updated: 2025-09-12

DIVIDENDS

KRMD does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales5.94
Price to Book10.72
EV to Sales5.97

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count46.23M
EPS (TTM)-0.26
FCF per share (TTM)-0.04

Income statement

Loading...
Income statement data
Revenue (TTM)31.99M
Gross profit (TTM)19.64M
Operating income (TTM)-7.05M
Net income (TTM)-11.97M
EPS (TTM)-0.26
EPS (1y forward)-0.01

Margins

Loading...
Margins data
Gross margin (TTM)61.39%
Operating margin (TTM)-22.05%
Profit margin (TTM)-37.42%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash8.81M
Net receivables5.24M
Total current assets18.93M
Goodwill0.00
Intangible assets746.30K
Property, plant and equipment10.96M
Total assets27.39M
Accounts payable1.67M
Short/Current long term debt4.24M
Total current liabilities6.32M
Total liabilities9.66M
Shareholder's equity17.73M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-162.53K
Capital expenditures (TTM)1.55M
Free cash flow (TTM)-1.71M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-67.51%
Return on Assets-43.71%
Return on Invested Capital-64.21%
Cash Return on Invested Capital-9.18%

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open4.12
Daily high4.21
Daily low4.09
Daily Volume74K
All-time high12.42
1y analyst estimate5.60
Beta0.47
EPS (TTM)-0.26
Dividend per share-
Ex-div date-
Next earnings date5 Nov 2025

Downside potential

Loading...
Downside potential data
KRMDS&P500
Current price drop from All-time high-66.91%-1.46%
Highest price drop-97.69%-56.47%
Date of highest drop17 Apr 20039 Mar 2009
Avg drop from high-57.84%-10.99%
Avg time to new high49 days12 days
Max time to new high3100 days1805 days
COMPANY DETAILS
KRMD (Repro Med Systems Inc) company logo
Marketcap
190.03M
Marketcap category
Small-cap
Description
KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.
Employees
80
Investor relations
-
SEC filings
CEO
Donald B. Pettigrew
Country
USA
City
Chester
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...